Trial · NCT03518034
Results by group64
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 64
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event | AndroGel 1.62% | 182 | Participants | ||
| Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event | Placebo | 190 | Participants | ||
| Time From Randomization to the First Component Event of MACE | AndroGel 1.62% | NA | 95% Confidence Interval NA to NA | months | |
| Time From Randomization to the First Component Event of MACE | Placebo | NA | 95% Confidence Interval NA to NA | months | |
| Time From Randomization to the First Component Event of CV Safety Endpoint: Number and Percentage of Participants With an Event | AndroGel 1.62% | 269 | Participants | ||
| Time From Randomization to the First Component Event of CV Safety Endpoint: Number and Percentage of Participants With an Event | Placebo | 264 | Participants | ||
| Time From Randomization to the First Component Event of CV Safety Endpoint | AndroGel 1.62% | NA | 95% Confidence Interval NA to NA | months | |
| Time From Randomization to the First Component Event of CV Safety Endpoint | Placebo | NA | 95% Confidence Interval NA to NA | months | |
| Incidence of High-Grade Prostate Cancer | AndroGel 1.62% | 5 | Participants | ||
| Incidence of High-Grade Prostate Cancer | Placebo | 3 | Participants | ||
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | AndroGel 1.62% | Change at Month 6 | 1.03 | 95% Confidence Interval 0.82 to 1.24 | score on a scale |
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | Placebo | Change at Month 6 | 0.54 | 95% Confidence Interval 0.32 to 0.75 | score on a scale |
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | AndroGel 1.62% | Change at Month 12 | 0.97 | 95% Confidence Interval 0.72 to 1.23 | score on a scale |
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | Placebo | Change at Month 12 | 0.50 | 95% Confidence Interval 0.25 to 0.76 | score on a scale |
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | AndroGel 1.62% | Change at Month 24 | 0.94 | 95% Confidence Interval 0.60 to 1.28 | score on a scale |
| Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Months 6, 12 and 24 | Placebo | Change at Month 24 | 0.46 | 95% Confidence Interval 0.11 to 0.82 | score on a scale |
| Number and Percentage of Participants Whose Persistent Depressive Disorder (PDD) Remits During Intervention Per Remission Definition | AndroGel 1.62% | Month 6 | 12 | Participants | |
| Number and Percentage of Participants Whose Persistent Depressive Disorder (PDD) Remits During Intervention Per Remission Definition | Placebo | Month 6 | 6 | Participants | |
| Number and Percentage of Participants Whose Persistent Depressive Disorder (PDD) Remits During Intervention Per Remission Definition | AndroGel 1.62% | Month 12 | 7 | Participants | |
| Number and Percentage of Participants Whose Persistent Depressive Disorder (PDD) Remits During Intervention Per Remission Definition | Placebo | Month 12 | 5 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03518034/results